Academic partner
of Lymphoma
Clinical Research

Research partnership

Recherche PartenarialeLYSARC has a long and successful experience of research partnerships, especially with leading pharmaceutical and biotechnology companies developing medicines and diagnostic tools for lymphoma. These partnerships are in accordance with the Charter of the relationship between the French Oncology Cooperative Groups coordination to which LYSARC belongs, and industry.

Through its participation in the CALYM Carnot Institute and GLOBAL CARE Initiative consortia, LYSARC is encouraged by the French government to develop its partnering research to contribute to the development of solutions to unmet medical needs in the diagnosis and treatment of lymphoma.